Discontinuation Rate of Newly Prescribed Donepezil in Alzheimer's Disease Patients in Asia

Discontinuation Rate of Newly Prescribed Donepezil in Alzheimer's Disease Patients in Asia

10.3988/jcn.2021.17.3.376

Saved in:
Bibliographic Details
Main Authors: Park, Kee Hyung, Yang, YoungSoon, Chen, Christopher, Shim, Yong S, Domingueze, Jacqueline C, Lee, Chan-Nyoung, Kang, Kyunghun, Kim, Hee-Jin, Jeong, Seul-Ki, Jeong, Jee Hyang, Hong, Zhen, Yoon, Soo Jin, Zhang, Zhen-Xin, Kim, Eun-Joo, Jang, Jae-Won, Li, Yansheng, Xu, Yun, Lin, Yu-Te, Qu, Qiumin, Hu, Chaur-Jong, Chou, Chih-Ho, Fan, Dongsheng, Kandiah, Nagaendran, Yang, Yuan-Han, Lau, Chi-ieong, Chu, Leung-Wing, Wang, Huali, Jung, San, Choi, Seong Hye, Kim, SangYun
Other Authors: PHARMACOLOGY
Format: Article
Language:English
Published: KOREAN NEUROLOGICAL ASSOC 2022
Subjects:
Science & Technology
Life Sciences & Biomedicine
Clinical Neurology
Neurosciences & Neurology
Alzheimer's disease
Asia
cognition
donepezil
LONG-TERM EFFICACY
DOUBLE-BLIND
CHOLINESTERASE-INHIBITORS
US MULTICENTER
OPEN-LABEL
SAFETY
PERSISTENCE
ADHERENCE
MODERATE
DEMENTIA
Online Access:https://scholarbank.nus.edu.sg/handle/10635/218741
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Language: English

Internet

https://scholarbank.nus.edu.sg/handle/10635/218741

Similar Items